XML 60 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
Employee Benefit Plans (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Stock-based compensation expense is included on the Consolidated Statements of Income and Comprehensive Income based upon the job functions of the employees receiving the grants.  Compensation expense related to EOG's stock-based compensation plans for the years ended December 31, 2023, 2022 and 2021 was as follows (in millions):
 202320222021
Lease and Well$54 $40 $49 
Gathering and Processing Costs4 4 3 
Exploration Costs24 15 20 
General and Administrative95 74 80 
Total$177 $133 $152 
Schedule of Vesting
The vesting schedules for grants of stock options, SARs, restricted stock and restricted stock units, and Performance Units are generally as follows:
Grant TypeVesting Schedule
Stock Options/SARsVesting in increments of one-third on each of the first three anniversaries, respectively, of the date of grant
Restricted Stock/Restricted Stock Units
"Cliff" vesting three years from the date of grant
Performance Units
"Cliff" vesting on the February 28th following the three-year performance period and the Compensation and Human Resources Committee's certification of the applicable performance multiple
Schedule of Weighted Average Fair Values and Valuation Assumptions
Weighted average fair values and valuation assumptions used to value stock option, SAR and ESPP grants for the years ended December 31, 2023, 2022 and 2021 were as follows:
 Stock Options/SARsESPP
 20222021202320222021
Weighted Average Fair Value of Grants
$28.30 $24.92 $29.35 $26.62 $18.12 
Expected Volatility42.20 %42.24 %38.01 %43.00 %51.27 %
Risk-Free Interest Rate0.89 %0.50 %5.02 %1.30 %0.07 %
Dividend Yield3.28 %2.26 %2.68 %2.89 %2.89 %
Expected Life5.3 years5.2 years0.5 years0.5 years0.5 years
Schedule of Share Based Compensation Arrangement By Share Based Payment Award
The following table sets forth the stock option and SAR transactions for the years ended December 31, 2023, 2022 and 2021 (stock options and SARs in thousands):
 202320222021
 Number
of Stock
Options/
SARs		Weighted
Average
Grant
Price		Number
of Stock
Options/
SARs		Weighted
Average
Grant
Price		Number
of Stock
Options/
SARs		Weighted
Average
Grant
Price
Outstanding at January 14,225 $77.49 9,969 $84.37 10,186 $84.08 
Granted— — 2 97.64 1,982 81.68 
Exercised (1)
(1,294)73.01 (5,526)89.70 (1,130)63.98 
Forfeited(88)87.74 (220)82.74 (1,069)98.15 
Outstanding at December 312,843 79.22 4,225 77.49 9,969 84.37 
Stock Options/SARs Exercisable at December 31
2,282 78.60 2,462 84.53 6,197 95.33 
(1)The total intrinsic value of stock options/SARs exercised during the years 2023, 2022 and 2021 was $70 million, $190 million and $27 million, respectively.  The intrinsic value is based upon the difference between the market price of the Common Stock on the date of exercise and the grant price of the stock options/SARs.
Schedule of Stock Options and SARs Outstanding and Exercisable
The following table summarizes certain information for the stock options and SARs outstanding and exercisable at December 31, 2023 (stock options and SARs in thousands):
Stock Options/SARs OutstandingStock Options/SARs Exercisable
Range of
Grant
Prices		Stock
Options/
SARs		Weighted
Average
Remaining
Life
(Years)		Weighted
Average
Grant
Price
 
 
Aggregate
Intrinsic
Value(1)
Stock
Options/
SARs		Weighted
Average
Remaining
Life
(Years)		Weighted
Average
Grant
Price
 
 
Aggregate
Intrinsic
Value (1)
$ 34.00 to $ 52.99
634 3$37.49  633 3$37.46   
53.00 to     80.99
380 374.99  376 375.03   
   81.00 to     81.99
1,140 581.81  588 481.81   
   82.00 to     96.99
246 195.97  242 196.09   
   97.00 to   129.99
443 2126.57  443 2126.58   
 2,843 379.22 $121 2,282 378.60 $99 
(1)Based upon the difference between the closing market price of the Common Stock on the last trading day of the year and the grant price of in-the-money stock options and SARs, in millions.
Schedule of ESPP Activity The following table summarizes ESPP activity for the years ended December 31, 2023, 2022 and 2021 (in thousands, except number of participants):
 202320222021
Approximate Number of Participants2,015 1,969 2,036 
Shares Purchased193 201 316 
Aggregate Purchase Price$18,759 $17,250 $17,224 
Schedule of Restricted Stock and Restricted Stock Unit Transactions
The following table sets forth the restricted stock and restricted stock unit transactions for the years ended December 31, 2023, 2022 and 2021 (shares and units in thousands):
 202320222021
 Number of Shares and UnitsWeighted Average Grant Date Fair ValueNumber of Shares and UnitsWeighted Average Grant Date Fair ValueNumber of Shares and UnitsWeighted Average Grant Date Fair Value
Outstanding at January 14,113 $80.77 4,680 $69.37 4,742 $74.97 
Granted1,680 131.10 1,637 113.21 1,422 81.50 
Released (1)
(1,295)42.03 (2,019)81.76 (1,388)101.00 
Forfeited(134)93.54 (185)68.89 (96)68.26 
Outstanding at December 31 (2)
4,364 111.24 4,113 80.77 4,680 69.37 
(1)
(1)The total intrinsic value of restricted stock and restricted stock units released during the years ended December 31, 2023, 2022 and 2021 was $166 million, $223 million and $110 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date restricted stock and restricted stock units are released.
(2)
(2)The total intrinsic value of restricted stock and restricted stock units outstanding at December 31, 2023, 2022 and 2021 was $528 million, $533 million and $416 million, respectively. The intrinsic value is based on the closing market price of the Common Stock on the last trading day of the year.
Schedule of Weighted Average Fair Values and Valuation Assumptions for Performance Units/Stocks Weighted average fair values and valuation assumptions used to value Performance Units during the years ended December 31, 2023, 2022 and 2021 were as follows:
 202320222021
Weighted Average Fair Value of Grants$142.20 $126.55 $95.16 
Expected Volatility44.76 %56.11 %53.80 %
Risk-Free Interest Rate4.53 %4.01 %0.59 %
Schedule of Performance Unit and Performance Stock Transactions
The following table sets forth the Performance Unit transactions for the years ended December 31, 2023, 2022 and 2021 (units in thousands):
 202320222021
 Number of UnitsWeighted Average Grant Date Fair ValueNumber of UnitsWeighted Average Grant Date Fair ValueNumber of UnitsWeighted Average Grant Date Fair Value
Outstanding at January 1688 $83.82 679 $84.97 613 $88.38 
Granted114 142.20 122 126.55 222 95.16 
Granted for Performance Multiple (1)
— — — — 19 113.81 
Released (2)
(86)79.98 (57)136.74 (175)113.06 
Forfeited for Performance Multiple (3)
(86)79.98 (56)136.74 — — 
Outstanding at December 31 (4)
630 (5)95.49 688 83.82 679 84.97 
(1)Upon completion of the performance period for the Performance Units granted in 2017, a performance multiple of 125% was applied to the grants resulting in additional grants of Performance Units in February 2021.
(2)The total intrinsic value of Performance Units released during the years ended December 31, 2023, 2022 and 2021 was $10 million, $7 million and $13 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date Performance Units are released.
(3)Upon completion of the performance period for the Performance Units granted in 2019 and 2018, a performance multiple of 50% was applied to each of the grants resulting in a forfeiture of Performance Units in both February 2023 and February 2022.
(4)The total intrinsic value of Performance Units outstanding at December 31, 2023, 2022 and 2021 was $76 million, $89 million and $60 million, respectively. The intrinsic value is based on the closing market price of the Common Stock on the last trading day of the year.
(5)Upon the application of the relevant performance multiple at the completion of each of the remaining performance periods, a minimum of zero and a maximum of 1,261 Performance Units could be outstanding.